GlassScriptPhysician profile
Frank Joseph Hux
NPI 1003030578
$7,156.49
in general payments reported to CMS, 2019-2025
14 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.95 · 2020: $57.80 · 2021: $475 · 2022: $811 · 2023: $2,690 · 2024: $1,951 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,959 · Travel and Lodging: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,958.98 |
| Travel and Lodging | $779.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osseus Fusion Systems, LLC | $4,137.90 | 2022-2025 | |
| Medtronic, INC. | $1,441.56 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $901.31 | 2020-2024 | |
| Abbott Laboratories | $251.85 | 2021-2025 | Eterna |
| Providence Medical Technology, INC. | $151.44 | 2022 | |
| Si-Bone, INC. | $73.95 | 2019 | |
| Shockwave Medical, INC | $50.81 | 2021 | |
| Depuy Synthes Sales INC. | $36.61 | 2020 | |
| Arbor Pharmaceuticals, INC. | $23.88 | 2021 | |
| Merck Sharp & Dohme LLC | $23.43 | 2023 | Bridion |
| Medela LLC | $18.75 | 2022-2023 | Invia Motion Endure |
| Acacia Pharma INC | $16.74 | 2022 | |
| Ulrich Medical USA, INC. | $14.61 | 2021 | |
| Kerecis Limited | $13.65 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Hux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.